FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Astrid Sasse

Research Profile

Chemicals & Drugs

Living Beings

Concepts & Ideas

Structure-Activity Relationship

Anatomy

Procedures

Co-author Network

Publications

TOP 3
Astrid Sasse; Xavier Ligneau; Agnès Rouleau; Sigurd Elz; C Robin Ganellin; Jean-Michel Arrang; Jean-Charles Schwartz; Walter Schunack; Holger Stark
Influence of bulky substituents on histamine h(3) receptor agonist/antagonist properties.
M Wiecek; K Kieć-Kononowicz; Astrid Sasse; Xavier Ligneau; Jean-Charles Schwartz; Walter Schunack; Holger Stark
Impact of lipophilicity on the pharmacological properties of histamine H3-receptor antagonists of the cycloalkyl carbamate class.
Jean-Charles Schwartz; Séverine Morisset; Agnès Rouleau; Joël Tardivel-Lacombe; Florence Gbahou; Xavier Ligneau; Anne Héron; Astrid Sasse; Holger Stark; Walter Schunack; R C Ganellin; Jean-Michel Arrang
Application of genomics to drug design: the example of the histamine H3 receptor.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Astrid Sasse (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2002: Astrid Sasse; Xavier Ligneau; Agnès Rouleau; Sigurd Elz; C Robin Ganellin; Jean-Michel Arrang; Jean-Charles Schwartz; Walter Schunack; Holger Stark
Influence of bulky substituents on histamine h(3) receptor agonist/antagonist properties.
Journal of medicinal chemistry 2002;45(18):4000-10.
2002: M Wiecek; K Kieć-Kononowicz; Astrid Sasse; Xavier Ligneau; Jean-Charles Schwartz; Walter Schunack; Holger Stark
Impact of lipophilicity on the pharmacological properties of histamine H3-receptor antagonists of the cycloalkyl carbamate class.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2002;51 Suppl 1():S71-2.
2001: Jean-Charles Schwartz; Séverine Morisset; Agnès Rouleau; Joël Tardivel-Lacombe; Florence Gbahou; Xavier Ligneau; Anne Héron; Astrid Sasse; Holger Stark; Walter Schunack; R C Ganellin; Jean-Michel Arrang
Application of genomics to drug design: the example of the histamine H3 receptor.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2001;11(6):441-8.
2001: Astrid Sasse; Xavier Ligneau; Bassem Sadek; Sigurd Elz; Heinz H Pertz; C Robin Ganellin; Jean-Michel Arrang; Jean-Charles Schwartz; Walter Schunack; Holger Stark
Benzophenone derivatives and related compounds as potent histamine H3-receptor antagonists and potential PET/SPECT ligands.
Archiv der Pharmazie 2001;334(2):45-52.
2001: Astrid Sasse; Walter Schunack; Holger Stark
Separation of chiral 4-substituted imidazole derivatives by cyclodextrin-modified capillary electrophoresis.
Biomedical chromatography : BMC 2001;15(1):25-30.
2001: Séverine Morisset; Astrid Sasse; Florence Gbahou; Anne Héron; Xavier Ligneau; Joël Tardivel-Lacombe; Jean-Charles Schwartz; Jean-Michel Arrang
The rat H3 receptor: gene organization and multiple isoforms.
Biochemical and biophysical research communications 2001;280(1):75-80.
2000: Astrid Sasse; Bassem Sadek; Xavier Ligneau; Sigurd Elz; Heinz H Pertz; Peter Luger; C Robin Ganellin; Jean-Michel Arrang; Jean-Charles Schwartz; Walter Schunack; Holger Stark
New histamine H(3)-receptor ligands of the proxifan series: imoproxifan and other selective antagonists with high oral in vivo potency.
Journal of medicinal chemistry 2000;43(17):3335-43.
2000: K Kieć-Kononowicz; M Wiecek; Astrid Sasse; Xavier Ligneau; Sigurd Elz; C Robin Ganellin; Jean-Charles Schwartz; Holger Stark; Walter Schunack
Importance of the lipophilic group in carbamates having histamine H3-receptor antagonist activity.
Die Pharmazie 2000;55(5):349-55.
2000: Astrid Sasse; Holger Stark; Xavier Ligneau; Sigurd Elz; S Reidemeister; C Robin Ganellin; Jean-Charles Schwartz; Walter Schunack
(Partial) agonist/antagonist properties of novel diarylalkyl carbamates on histamine H3 receptors.
Bioorganic & medicinal chemistry 2000;8(5):1139-49.
1999: Astrid Sasse; Holger Stark; S Reidemeister; Annette Hüls; Sigurd Elz; Xavier Ligneau; C Robin Ganellin; Jean-Charles Schwartz; Walter Schunack
Novel partial agonists for the histamine H(3) receptor with high in vitro and in vivo activity.
Journal of medicinal chemistry 1999;42(20):4269-74.
1999: Astrid Sasse; Katarzyna Kiec-Kononowicz; Holger Stark; Maciej Motyl; S Reidemeister; C Robin Ganellin; Xavier Ligneau; Jean-Charles Schwartz; Walter Schunack
Development of chiral N-alkylcarbamates as new leads for potent and selective H3-receptor antagonists: synthesis, capillary electrophoresis, and in vitro and oral in vivo activity.
Journal of medicinal chemistry 1999;42(4):593-600.